Drug Development Research · 1986 · 31 citations · 15 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyGastroenterologyGastrointestinal PharmacotherapyConstipation ManagementGastroesophageal Reflux DiseaseGastrointestinal MotilityGastrointestinal PharmacologyProkinetic TherapyGastric SecretionGastroesophageal Reflux Disease PharmacotherapyLower Gastrointestinal Motility TreatmentMotor Coordination DisordersMuscarinic ReceptorsProkinetic Drug PharmacologySmall Intestinal FunctionSmall Intestinal Motility
Abstract Cisapride is a new gastrointestinal prokinetic substance that is devoid of antidopaminergic and direct muscarinic activity. This was evidenced by a lack of effect on prolactin release and gastric secretion. In man, cisapride stimulates lower esophageal, gastric, small intestinal, and colonic motility. Accordingly, cisapride significantly improves esophageal reflux disorders, gastroparesis, and constipation and has been successfully used in the treatment of clinical conditions that result from a deficient motor coordination.
15
Raymond Jian, F Ducrot, C Piedeloup et al. · Gut · 1985 · 151 citations · Full text
FAMINE AND MALNUTRITION IN EUROPE
J. E. Drummond · The Lancet · 1946 · 145 citations